Novo Nordisk's 7.2 mg dose of Wegovy will compete against Lilly's GLP-1 injection Novo Nordisk's high-dose version of Wegovy received approval Thursday from the Food and Drug Administration. A higher ... Fierce Healthcare: GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month Alongside the $399 monthly dose, patients can choose to get a two-month supply for $798 or a three-month supply for $1,197.

Understanding the Context

GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month MarketWatch: Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy(R), offering savings of up to $1,200/year Novo Nordisk today announced a new multi-month subscription program for Wegovy (R) (semaglutide) that provides eligible self-pay patients who enroll in the program through select telehealth providers ... Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy(R), offering savings of up to $1,200/year USA TODAY on MSN: Foundayo, Wegovy and how GLP-1 weight-loss pills compare to shots